• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Lipid treatment goals achieved in patients treated with statin drugs in Norwegian general practice.

作者信息

Svilaas A, Risberg K, Thoresen M, Ose L

机构信息

Lipid Clinic, Medical Department, Rikshospitalet, Oslo, Norway.

出版信息

Am J Cardiol. 2000 Dec 1;86(11):1250-3, A6. doi: 10.1016/s0002-9149(00)01212-1.

DOI:10.1016/s0002-9149(00)01212-1
PMID:11090801
Abstract

Statin drug treatment has still not achieved complete acceptance, and titration to recommended target goals is still not used by physicians in Norway.

摘要

相似文献

1
Lipid treatment goals achieved in patients treated with statin drugs in Norwegian general practice.
Am J Cardiol. 2000 Dec 1;86(11):1250-3, A6. doi: 10.1016/s0002-9149(00)01212-1.
2
Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins.使用五种他汀类药物实现并维持国家胆固醇教育计划的低密度脂蛋白胆固醇目标
Am J Med. 2001 Aug 15;111(3):185-91. doi: 10.1016/s0002-9343(01)00799-9.
3
Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.在常规临床实践中，与其他他汀类药物相比，瑞舒伐他汀治疗的老年患者的低密度脂蛋白胆固醇（LDL-C）水平及LDL-C达标情况。
Am J Geriatr Pharmacother. 2007 Sep;5(3):185-94. doi: 10.1016/j.amjopharm.2007.10.002.
4
Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.西班牙降胆固醇疗法的成本效益分析。
Am J Cardiovasc Drugs. 2006;6(3):177-88. doi: 10.2165/00129784-200606030-00005.
5
Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects.冠心病患者与对照受试者中他汀类药物（阿托伐他汀、氟伐他汀、洛伐他汀、普伐他汀和辛伐他汀）对空腹和餐后脂蛋白影响的比较。
Am J Cardiol. 2004 Jan 1;93(1):31-9. doi: 10.1016/j.amjcard.2003.09.008.
6
Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin.使用阿托伐他汀、氟伐他汀、洛伐他汀和辛伐他汀，将有动脉粥样硬化记录的患者的低密度脂蛋白胆固醇水平治疗至国家胆固醇教育计划推荐的目标。
J Am Coll Cardiol. 1998 Sep;32(3):665-72. doi: 10.1016/s0735-1097(98)00300-3.
7
Variable influence of statins on isoprostanes in hyperlipidemia.
Adv Exp Med Biol. 2003;525:209-12. doi: 10.1007/978-1-4419-9194-2_45.
8
Statin therapy--what now?
Drug Ther Bull. 2001 Mar;39(3):17-21. doi: 10.1136/dtb.2001.39317.
9
Long-term safety and efficacy of combination gemfibrozil and HMG-CoA reductase inhibitors for the treatment of mixed lipid disorders.吉非贝齐与HMG-CoA还原酶抑制剂联合治疗混合性血脂异常的长期安全性和疗效。
Am Heart J. 1999 Jul;138(1 Pt 1):151-5. doi: 10.1016/s0002-8703(99)70261-9.
10
A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.一项在社区开展的随机试验，研究在他汀类药物治疗基础上加用依折麦布，以实现高胆固醇血症患者达到美国国家胆固醇教育计划成人治疗组第三次报告（NCEP ATP III）的低密度脂蛋白胆固醇目标：依折麦布加用他汀类药物有效性（EASE）试验。
Mayo Clin Proc. 2005 May;80(5):587-95. doi: 10.4065/80.5.587.

引用本文的文献

1
Impact of treatment with rosuvastatin and atorvastatin on cardiovascular outcomes: evidence from the Archimedes-simulated clinical trials.瑞舒伐他汀和阿托伐他汀治疗对心血管结局的影响：来自阿基米德模拟临床试验的证据。
Clinicoecon Outcomes Res. 2015 Nov 27;7:555-65. doi: 10.2147/CEOR.S88817. eCollection 2015.
2
Prevalence of dyslipidemia in statin-treated patients in Canada: results of the DYSlipidemia International Study (DYSIS).加拿大接受他汀类药物治疗的患者血脂异常患病率：国际血脂异常研究（DYSlipidemia）的结果。
Can J Cardiol. 2010 Nov;26(9):e330-5. doi: 10.1016/s0828-282x(10)70454-2.
3
Trends in total cholesterol screening and in prescribing lipid-lowering drugs in general practice in the period 1994-2003.
1994年至2003年期间全科医疗中总胆固醇筛查及降脂药物处方的趋势。
BMC Fam Pract. 2008 Jun 30;9:39. doi: 10.1186/1471-2296-9-39.
4
Rational prescribing in primary care (RaPP): a cluster randomized trial of a tailored intervention.基层医疗中的合理用药（RaPP）：一项量身定制干预措施的整群随机试验。
PLoS Med. 2006 Jun;3(6):e134. doi: 10.1371/journal.pmed.0030134.
5
Whom are we treating with lipid-lowering drugs? Are we following the guidelines? Evidence from a population-based study: the Tromso study 2001.我们在给哪些人使用降脂药物？我们是否遵循了指南？一项基于人群的研究证据：特罗姆瑟研究2001。
Eur J Clin Pharmacol. 2004 Nov;60(9):643-9. doi: 10.1007/s00228-004-0827-z. Epub 2004 Sep 29.
6
Improving prescribing of antihypertensive and cholesterol-lowering drugs: a method for identifying and addressing barriers to change.改善抗高血压和降胆固醇药物的处方：一种识别和解决变革障碍的方法。
BMC Health Serv Res. 2004 Sep 3;4(1):23. doi: 10.1186/1472-6963-4-23.
7
Undertreatment of hypercholesterolaemia: a population-based study.高胆固醇血症治疗不足：一项基于人群的研究。
Br J Clin Pharmacol. 2003 Apr;55(4):389-97. doi: 10.1046/j.1365-2125.2003.01769.x.
8
Rational Prescribing in Primary Care (RaPP-trial). A randomised trial of a tailored intervention to improve prescribing of antihypertensive and cholesterol-lowering drugs in general practice [ISRCTN48751230].基层医疗中的合理用药（RaPP试验）。一项关于量身定制干预措施以改善全科医疗中抗高血压和降胆固醇药物处方的随机试验[ISRCTN48751230]。
BMC Health Serv Res. 2003 Feb 27;3(1):5. doi: 10.1186/1472-6963-3-5.
9
Time trends in lipid lowering drug use in The Netherlands. Has the backlog of candidates for treatment been eliminated?荷兰降脂药物使用的时间趋势。治疗候选者的积压情况是否已消除？
Br J Clin Pharmacol. 2002 Apr;53(4):379-85. doi: 10.1046/j.1365-2125.2002.01562.x.